{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:35:51Z","timestamp":1787502951451,"version":"build-2736575974"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:p>This cross-sectional study examines the increase in positive results for John Cunningham virus antibodies and higher risk for progressive multifocal leukoencephalopathy among patients with multiple sclerosis receiving natalizumab.<\/jats:p>","DOI":"10.1001\/jamaneurol.2025.0337","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T11:36:51Z","timestamp":1743421011000},"page":"523","source":"Crossref","is-referenced-by-count":10,"title":["Accuracy of New John Cunningham Virus Antibody Assay in Natalizumab-Treated Patients With Multiple Sclerosis"],"prefix":"10.1001","volume":"82","author":[{"given":"Liza M. Y.","family":"Gelissen","sequence":"first","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn T.","family":"Wijburg","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M. M.","family":"Strijbis","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob W.","family":"van Oosten","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigit A.","family":"de Jong","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard M. J.","family":"Uitdehaag","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[{"name":"Research and Lab Services Department, Sanquin Blood Supply, Amsterdam, the Netherlands"},{"name":"Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariet C. W.","family":"Feltkamp","sequence":"additional","affiliation":[{"name":"Research and Lab Services Department, Sanquin Blood Supply, Amsterdam, the Netherlands"},{"name":"Department of Medical Microbiology and Infection Prevention, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00e9 L. E.","family":"van Kempen","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC) location Boelelaan, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"nld250003r1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"nld250003r2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","article-title":"A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.","volume":"57","author":"Lee","year":"2013","journal-title":"J Clin Virol"},{"issue":"11","key":"nld250003r4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(17)30282-X","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.","volume":"16","author":"Ho","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"nld250003r6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamaneurol.2022.5007","article-title":"Efficacy and safety of proposed biosimilar natalizumab (PB006) in patients with relapsing-remitting multiple sclerosis: the Antelope phase 3 randomized clinical trial.","volume":"80","author":"Hemmer","year":"2023","journal-title":"JAMA Neurol"},{"key":"nld250003r3","unstructured":"European Medicines Agency. Assessment report: Tyruko. International non-proprietary name: natalizumab. 2023. Accessed October 15, 2024. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/tyruko-epar-public-assessment-report_en.pdf"},{"key":"nld250003r5","unstructured":"Adler? F, Andersen? M, Bartl? T, . A new assay for detection of anti-JCV antibodies to support risk stratification and monitoring for progressive multifocal leukoencephalopathy in patients considering or in treatment with natalizumab. Poster presented at the European Committee for Treatment and Research in Multiple Sclerosis Congress; September 18, 2024; Copenhagen, Denmark. Accessed November 25, 2024. https:\/\/www.charcot-ms.org\/files\/ID-99-Maja-Natek.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2831921\/jamaneurology_gelissen_2025_ld_250003_1755020520.25738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:00:56Z","timestamp":1755097256000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2831921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.0337","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}